Ahmedabad, 06 November, 2025:Marengo CIMS Hospital proudly announces a significant breakthrough in advanced cancer treatment with the successful administration of its first CAR-T (Chimeric Antigen Receptor T-cell) therapy. This therapy was performedon a patient suffering from relapsed B-cell Acute Lymphoblastic Leukemia (ALL), marking a pivotal moment in thehospital’s commitment to providing cutting-edge oncology care.
CAR-T therapy represents one of the most advanced and revolutionary treatments for certain blood cancers. Itinvolves genetically modifying a patient’s own T-cells to target and destroy cancer cells effectively. Traditionally, this therapy has been associated with extremely high costs, making it inaccessible to most patients. However,Marengo CIMS Hospital has made this life-saving treatment more affordable, bringing hope to many patients inGujarat and beyond.
The therapy was successfully carried out under the leadership of Dr. Kaumil Patel, Consultant Hematologist,Hemato-Oncologist, and BMT Physician, with the crucial support of Dr. Bhavesh Parekh, Head of Medical Oncology,and their dedicated teams. This collaborative effort highlights Marengo CIMS Hospital’s multidisciplinary approach tocomplex cancer care.
“Performing the first CAR-T infusion at Marengo CIMS Hospital is not just a medical achievement; it is a stepforward in making world-class cancer therapy accessible to patients who need it the most,” said Dr. Kaumil Patel, thetreating physician. “Our team’s goal is to combine expertise, innovation, and compassion to give patients the bestpossible chance for recovery.”
The patient, who had relapsed after conventional treatments, responded well to CAR-T therapy and is underclose monitoring by the hospital’s oncology and hematology teams. CAR-T therapy works by reprogramming thepatient’s immune system to recognize and destroy cancer cells, often providing results in cases where other therapieshave failed.
Dr. R. Shankaran, Unit Medical Director, emphasized the transformative potential of this therapy: “CAR-T therapy isa game-changer in the field of hematologic cancers. It allows us to offer a personalized and highly effective treatmentoption that was previously out of reach for most patients due to cost and availability.”
Dr. Keyur Parikh, Interventional Cardiologist and Chairman of Marengo CIMS Hospital, stated,“At MarengoCIMS, we believe true healthcare excellence lies in bridging the gap between innovation and accessibility. Thesuccessful implementation of CAR-T therapy is not just a medical triumph but a promise — that world-class,life-saving treatments can and should be available to every patient, right here in India. This milestone reinforces ourvision of placing India at the forefront of advanced and affordable healthcare.”
Dr. RaajivSinghal, Founding Member, Managing Director & Group CEO Marengo Asia Hospitals, “At MarengoAsia Hospitals, our commitment is clear—to deliver clinical excellence backed by advanced technology, expert teams,and a strong patient-first philosophy. The successful administration of CAR-T therapy is a reflection of our ability tobring global-standard treatments within reach of patients in India. We are not just treating disease; we are creating access to the most sophisticated therapies through world-class infrastructure, specialised talent, and outcome-driven care pathways. As we expand our capabilities, our objective remains consistent—to set new benchmarks in oncologyand across specialties, strengthen trust in our healthcare delivery model, and ensure every patient receives precisionled, compassionate and reliable care.”
Marengo CIMS Hospital is now among the few centers in Gujarat offering CAR-T therapy, positioning it at theforefront of cancer treatment in India. The hospital plans to expand its CAR-T program to include additional bloodcancers and continue improving patient access to this advanced therapy.
This achievement underscores Marengo CIMS Hospital’s dedication to medical innovation, multidisciplinarycollaboration, and patient-centric care. With CAR-T therapy now available locally, patients no longer have to travelabroad for this cutting-edge treatment, significantly reducing the financial and emotional burden on families.
